Haleon

Haleon is a public consumer healthcare company created through the 2022 demerger of GSK’s consumer healthcare business. Its portfolio includes brands such as Sensodyne, Centrum, Advil, Voltaren, Panadol, Aquafresh, and Tums. Haleon’s sustainability relevance is concentrated in Scope 3 emissions, packaging, ingredient sourcing, contract manufacturing, product lifecycle impacts, responsible sourcing, and access to health. The company uses supplier sustainability guidance, carbon pricing in procurement, packaging decarbonization expectations, and ESG reporting systems to link supply-chain performance to its 2030 and 2040 climate targets.